Oxelumab
From Wikipedia, the free encyclopedia
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | OX-40 ligand |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| Chemical and physical data | |
| Formula | C6424H9920N1704O2014S42 |
| Molar mass | 144594.46 g·mol−1 |
  (what is this?) (verify) | |
Oxelumab is a human monoclonal antibody targeting OX40L designed for the treatment of asthma.[1][2]
Oxelumab was developed by Genentech and co-developed by Roche.
